The results showed a trend of worse PFS and a significantly shorter OS (HR = 1.43, 95% CI = 1.02–2.00) compared with patients with wild-type tumors.
← all excerpts
Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer.
1
—
—